Navigation Links
Arsenal Capital Partners Invests in DG3

Partners with Management to Create Leading, Full-Service Global Graphic

Communication Services Organization

NEW YORK, April 9, 2008 /PRNewswire/ -- Arsenal Capital Partners, a leading New York-based private equity firm that invests in middle-market specialty industrial, healthcare and financial services companies, today announced that it has completed its acquisition of Diversified Global Graphics Group ("DG3"). Arsenal and the company's management team, led by CEO Dr. Michael Cunningham, acquired DG3 in a proprietary transaction directly from Peter Furlonge the majority shareholder and former Chairman.

DG3 is a leading, global provider of commercial printing and graphic communication services and has annual revenues of $150 million. DG3 markets its services to a diverse base of blue-chip customers in the financial, pharmaceutical, academic and corporate markets, and serves these customers on a global basis from operations in North America, Europe and Asia.

Dr. Michael Cunningham, who founded DG3, formerly known as Cunningham Graphics International Inc. in 1989 and took it public in 1998 (Nasdaq:CGII), recently re-joined the company. Dr. Cunningham, who received his doctorate from New York University, is a Clinical Professor of Entrepreneurship at the San Diego State University College of Business Administration, where he teaches international business strategy and business planning. He is also a Research Professor from Industry at Cal Poly's graphic communications department and an Adjunct Associate Professor at New York University.

The management team and Board of the company will be strengthened with the addition of Laurence H. Bloch as its new Chairman. Mr. Bloch is a publishing industry veteran who most recently was the Chairman of TransWestern Holdings, a leading U.S. telephone directory publisher. At TransWestern, Mr. Bloch was instrumental in growing the business organically and through numerous acquisitions from approximately $35 million to $1.6 billion in enterprise value. Messrs. Cunningham and Bloch, as well as other key members of senior management, will hold significant equity interests in the company. Peter Furlonge, former Chairman of DG3 will remain as an advisor and has made an investment in the company.

Terrence Mullen, a Managing Director of Arsenal Capital, commented, "We are pleased to add DG3 to the Arsenal portfolio of companies. Our priority is to support management's growth strategy as a customer centric provider to select vertical markets and use our prior investment experience in the printing sector to enhance the business and create a leading, full-service global graphic communications company that is differentiated by its focused approach to providing superior customer service."

"Our new partnership with Arsenal will provide us with additional resources that will help us capture the many opportunities that exist to further penetrate global end markets and broaden service offerings to include higher value process and technology-oriented products and services," said Dr. Cunningham. "I look forward to working with Arsenal, my world class management team and my good friend Larry Bloch to continue to build on the accomplishments we have achieved over the past few years in making DG3 the best in class full service global graphic communications company. I am especially pleased with the high level of management participation in this transaction."

Mr. Bloch commented, "DG3 provides a strong platform by which we can grow the business both organically and through targeted acquisitions that will help expand the company's markets geographically and into targeted verticals. The strong management team is supported by a talented and energetic global workforce that will be instrumental in building the business."

Arsenal's investments in this sector include TallyGenicom, a leader in the impact printer industry, and it previous investment in Renaissance Mark, one of the largest North American providers of prime labels and brand imaging solutions to the packaging industry.

Equity financing for the transaction was provided from Arsenal Capital Partners' $500 million Fund II. Debt financing was provided by Bank of America. Kirkland & Ellis LLP was legal advisor to Arsenal Capital.

About Arsenal Capital Partners

Arsenal Capital Partners is a New York-based private equity firm that makes investments in specialty industrial, healthcare and financial services companies. Arsenal makes investments in sectors where the firm has prior knowledge and experience, and targets businesses that have the potential for further value creation by working closely with management to accelerate growth and leverage the firm's operational improvement capabilities. Arsenal currently has $800 million of committed equity capital. For additional information on Arsenal Capital Partners please visit

About the DG3 Group

DG3 is a leading provider of global print and graphic communication solutions operating in strategic geographic markets including Jersey City, London, Hong Kong, Tokyo, Sydney, and Manila. DG3 provides comprehensive graphic communication solutions to corporations, financial services firms, pharmaceutical and academic institutions worldwide. For more information please visit

Contact: Chris Tofalli

Chris Tofalli Public Relations, LLC


SOURCE Arsenal Capital Partners
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. TeamStaff Announces Amended Revolving Credit Facility with Sovereign Business Capital
2. Bionovo to Present at the Cambria Capital Investor Meeting
3. Golub Capital Provides $29.5 Million GOLD Facility in Support of the Recapitalization of ExtruMed
4. Capital BlueCross Receives Prestigious Brand Excellence Award From The Blue Cross & Blue Shield Association
5. Super Model Cindy Crawford will be Honored at DKMS Linked Against Leukemia Gala on May 7th at Capitale
6. St. Alcuin Montessori School Announces $5 Million Capital Campaign Gift
7. InforMedix Retains Murdock Capital Partners
8. LifeMasters Strengthens Capital Structure with $15 Million in Funding from Existing Investors
9. Avista Capital Partners Enhances Energy Practice With Appointment of Gerhard Kurz
10. HealthpointCapital, LLC Appoints Stephen H. Hochschuler, M.D. as Clinical Advisor
11. MaxLife Fund Corp. and Capital Growth Planning Inc., sign a joint venture agreement
Post Your Comments:
(Date:11/26/2015)... ... 2015 , ... PRMA Plastic Surgery is updating their record books yet again ... free flap breast reconstruction surgery! , “What an accomplishment for the PRMA team, says ... and it’s an honor to have served all of these women.” , PRMA is ...
(Date:11/26/2015)... ... November 26, 2015 , ... Indosoft Inc., developer and distributor of the ... to improve system efficiency and reliability. , The new Q-Suite 6 platform is based ... system avoids locking itself into a specific piece of software for many key components ...
(Date:11/25/2015)... ... November 25, 2015 , ... Finnleo, a leader in ... on several models of traditional and far-infrared saunas. , For traditional saunas, ... the most traditional Finnish sauna wood, and Finnleo uses only European Grade A Nordic ...
(Date:11/25/2015)... ... November 26, 2015 , ... Ministers, senior government ... ANDI Pan African Centres of Excellence, and public R&D institutions, civil societies and ... opening of the 5th African Network for Drugs and Diagnostics Innovation, ANDI, Stakeholders ...
(Date:11/25/2015)... FL (PRWEB) , ... November 25, 2015 , ... ... center, is encouraging people across the country to celebrate their sobriety and show ... people to post “before and after” photos this Thanksgiving with the hashtag #FacesOfGratitude ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 2015 --> ... blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer.   ... immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer.   ... that immunotherapy can be efficiently combined with photodynamic therapy ...
(Date:11/26/2015)... --> --> Juntendo University ... contrast weighting of MRI for patients with Multiple Sclerosis ... agreement with SyntheticMR in order to use SyMRI in clinical ... to generate multiple contrast images from a single scan and ... making it possible to both fine tune images and recreate ...
(Date:11/26/2015)... SAN FRANCISCO , November 26, 2015 ... 1.82 billion by 2022, according to a new report by ... as Chronic Kidney Disease (CKD) which demands kidney transplantation is ... convenient and cost effective substitute for organ transplantation. --> ... 1.82 billion by 2022, according to a new report by ...
Breaking Medicine Technology: